Dongbang Medical Co., Ltd (KOSDAQ:240550)
South Korea
· Delayed Price · Currency is KRW
6,740.00
+330.00 (5.15%)
Mar 10, 2026, 3:30 PM KST
Dongbang Medical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Debt / Equity Ratio | 0.32 | 0.54 | 0.59 | 0.81 |
| Debt / EBITDA Ratio | 1.88 | 2.00 | 1.41 | 3.18 |
| Debt / FCF Ratio | - | 8.01 | 17.64 | 7.86 |
| Net Debt / Equity Ratio | 0.02 | 0.33 | 0.29 | 0.36 |
| Net Debt / EBITDA Ratio | 0.11 | 1.22 | 0.68 | 1.43 |
| Net Debt / FCF Ratio | -0.47 | 4.88 | 8.53 | 3.53 |
| Asset Turnover | 0.68 | 0.79 | 0.79 | - |
| Inventory Turnover | 2.21 | 2.29 | 2.22 | - |
| Quick Ratio | 1.22 | 0.73 | 0.68 | 0.61 |
| Current Ratio | 2.06 | 1.44 | 1.36 | 1.13 |
| Return on Equity (ROE) | 9.52% | 4.64% | 20.18% | - |
| Return on Assets (ROA) | 5.34% | 7.24% | 9.31% | - |
| Return on Invested Capital (ROIC) | 9.10% | 8.08% | 21.00% | 5.67% |
| Return on Capital Employed (ROCE) | 10.10% | 15.50% | 24.50% | 9.20% |
| Buyback Yield / Dilution | -9.83% | 7.51% | -17.90% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.